Boston-based healthcare company Heranova Lifesciences, focusing on women’s reproductive health, pregnancy, and menopause, has launched with $13.5 million in seed and seed+ funding. The company offers diagnostic testing and therapeutics for endometriosis, bacterial vaginosis, genetic testing, and fertility. They plan to develop non-invasive endometriosis tests and therapeutic programs for bacterial vaginosis and endometriosis with the funding. Women’s health tech is a growing sector, with companies like Maven Clinic, Diana Health, Kindbody, and Iron Health also receiving significant funding for digital health innovations. Heranova aims to provide convenient and reliable diagnostic tests for women’s diseases, ultimately shortening the time from disease onset to diagnosis and treatment.
Source link
Women’s health company Heranova Lifesciences launches with $13.5M
